Efficacy and safety of liraglutide added to insulin treatment in type 1 diabetes: the ADJUNCT ONE treat-to-target randomized trial
C Mathieu, B Zinman, JU Hemmingsson, V Woo… - Diabetes …, 2016 - Am Diabetes Assoc
OBJECTIVE To investigate whether liraglutide added to treat-to-target insulin improves
glycemic control and reduces insulin requirements and body weight in subjects with type 1 …
glycemic control and reduces insulin requirements and body weight in subjects with type 1 …
Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial
C Mathieu, B Zinman, JU Hemmingsson, V Woo… - Diabetes …, 2016 - swepub.kb.se
To investigate whether liraglutide added to treat-to-target insulin improves glycemic control
and reduces insulin requirements and body weight in subjects with type 1 diabetes …
and reduces insulin requirements and body weight in subjects with type 1 diabetes …
Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial.
C Mathieu, B Zinman, JU Hemmingsson… - Diabetes …, 2016 - search.ebscohost.com
Abstract < bold> Objective: </bold> To investigate whether liraglutide added to treat-
to-target insulin improves glycemic control and reduces insulin requirements and body …
to-target insulin improves glycemic control and reduces insulin requirements and body …
Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial
C Mathieu, B Zinman, JU Hemmingsson, V Woo… - Diabetes Care, 2016 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> OBJECTIVE</jats: title>< jats: p> To investigate whether
liraglutide added to treat-to-target insulin improves glycemic control and reduces insulin …
liraglutide added to treat-to-target insulin improves glycemic control and reduces insulin …
Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial
C Mathieu, B Zinman, JU Hemmingsson… - Diabetes …, 2016 - pubmed.ncbi.nlm.nih.gov
Objective To investigate whether liraglutide added to treat-to-target insulin improves
glycemic control and reduces insulin requirements and body weight in subjects with type 1 …
glycemic control and reduces insulin requirements and body weight in subjects with type 1 …
Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial
C Mathieu, B Zinman, JU Hemmingsson, V Woo… - Diabetes Care, 2016 - hero.epa.gov
OBJECTIVE: To investigate whether liraglutide added to treat-to-target insulin improves
glycemic control and reduces insulin requirements and body weight in subjects with type 1 …
glycemic control and reduces insulin requirements and body weight in subjects with type 1 …
[PDF][PDF] Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial
Diabetes Care, 2016 - researchgate.net
Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT
ONE Treat-To-Target Randomized Tri Page 1 Efficacy and Safety of Liraglutide Added to Insulin …
ONE Treat-To-Target Randomized Tri Page 1 Efficacy and Safety of Liraglutide Added to Insulin …
Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial.
C Mathieu, B Zinman, JU Hemmingsson, V Woo… - Diabetes …, 2016 - europepmc.org
Objective To investigate whether liraglutide added to treat-to-target insulin improves
glycemic control and reduces insulin requirements and body weight in subjects with type 1 …
glycemic control and reduces insulin requirements and body weight in subjects with type 1 …